Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dare Bioscience Inc (NQ: DARE ) 0.4345 +0.0128 (+3.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Dare Bioscience Inc < Previous 1 2 3 4 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 03, 2023 We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning! Via InvestorPlace Earnings Preview: Dare Bioscience March 29, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 02, 2023 Via Benzinga Daré Bioscience Shares Move Higher Intravaginal Ring Shows Promise In Menopause Symptoms January 09, 2023 Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Dare Bioscience: Here's What You Need To Know December 13, 2022 Via Benzinga Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow November 14, 2022 Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options. Via Benzinga Daré Bioscience's Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause October 17, 2022 Via Benzinga Dare Bioscience: Q1 Earnings Insights May 12, 2022 Dare Bioscience (NASDAQ:DARE) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 December 01, 2022 Via Benzinga Can This Company’s Birth Control Patch Disrupt The Contraceptive Market? October 26, 2022 From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,... Via TheNewswire.com Can This Company’s Birth Control Patch Disrupt The Contraceptive Market? October 26, 2022 By Ernest Dela Aglanu, Benzinga Via News Direct Recap: Dare Bioscience Q4 Earnings March 31, 2022 Dare Bioscience (NASDAQ:DARE) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Can This Company's Birth Control Patch Disrupt The Contraceptive Market? October 25, 2022 From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,... Via Benzinga Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Outlook For Dare Bioscience August 08, 2022 Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Dare... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 25, 2022 Gainers Via Benzinga President Biden Mulls Health Emergency For Abortion Access: Report July 11, 2022 Via Benzinga The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug July 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session July 07, 2022 Gainers Via Benzinga EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision June 27, 2022 Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch. Via InvestorPlace 3 Women's Health Stocks Are Soaring Following Roe v. Wade Ruling June 27, 2022 Three days after the U.S. Supreme Court struck down Roe v. Wade in one of the most potentially impactful rulings of the last century, a handful of women's health stocks are on the move on Monday in... Via Benzinga The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More May 12, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Preview: Dare Bioscience May 11, 2022 Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Dare... Via Benzinga Organon Inks Licensing Pact For Daré Bioscience's Bacterial Vaginosis Treatment March 31, 2022 Organon & Co (NYSE: OGN) Via Benzinga Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV) March 31, 2022 From Organon & Co. Via Business Wire Earnings Scheduled For March 31, 2022 March 31, 2022 Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter. Via Benzinga Earnings Preview: Dare Bioscience March 30, 2022 Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Dare... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 29, 2021 Gainers Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 12.6% to $1.34 during Wednesday's pre-market session. The market value of their outstanding shares is... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 27, 2021 Gainers OptiNose (NASDAQ:OPTN) shares mov... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 09, 2021 Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.